Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacturing of health care, personal care and home care products.
Finecure Pharmaceuticals Limited, is an unlisted others company incorporated on 18 March, 2005. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 12.71 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Mukesh Tarachand Agarwal | 00118813 | 9 years |
| Director | Anshu Krishnakumar Agrawal | 07931194 | 9 years |
| Director | Niraj Kumar Harodia | 06676837 | 2 years |
| Managing Director | Vikash Rajgarhia
Shareholder
|
00225426 | 9 years |
| Whole-time director | Vivek Rajgarhia
Shareholder
|
00225406 | 16 years |
| Whole-time director | Vishal Haremurari Rajgarhia
Shareholder
|
00225415 | 9 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Standard Chartered Bank
No. of Loans: 1
Total Amount : 35.0 cr
Small Industries Development Bank of India
No. of Loans: 2
Total Amount : 24.2 cr
Kotak Mahindra Bank Limited
No. of Loans: 2
Total Amount : 6.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| KASHISH TEX PRIVATE LIMITED |
Active
|
18.9 L | 1 | Gujarat |
| FINEBIOTICS PHARMA LIMITED |
Active
|
11.5 Cr | 3 | Gujarat |
| GLOBAL MEDISCIENCES LIMITED |
Active
|
40.6 L | 3 | Gujarat |
| FINECURE FOUNDATION |
Active
|
5.0 L | 3 | Gujarat |
| THE GROB TEA CO LTD |
Active
|
1.2 Cr | 1 | |
| JPNR CORPORATE CONSULTANTS PRIVATE LIMITED |
Active
|
1.9 L | 1 | West Bengal |
| TECHOGRAFIX IMPACT PRIVATE LIMITED |
Active
|
2.0 Cr | 1 |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| FINECURE FOUNDATION | Gujarat | 2021 | ₹ 5.0 L |
Read more
The incorporation date of FINECURE PHARMACEUTICALS LIMITED is 18 March, 2005
The authorized share capital of FINECURE PHARMACEUTICALS LIMITED is INR ₹ 20.0 Cr.
The paid-up capital of FINECURE PHARMACEUTICALS LIMITED is INR ₹ 12.7 Cr.
The registered address of FINECURE PHARMACEUTICALS LIMITED is A-1201, MONDEAL HEIGHTS, NR. WIDE ANGLE, S.G. HIGHWAY AHMEDABAD Gujarat - 380015
The CIN number of FINECURE PHARMACEUTICALS LIMITED is U24230GJ2005PLC045724.